John L. Leguyader

Array ( [id] => 1216042 [patent_doc_number] => 06706474 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-16 [patent_title] => 'Nucleic acid enzyme biosensors for ions' [patent_app_type] => B1 [patent_app_number] => 09/605558 [patent_app_country] => US [patent_app_date] => 2000-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 21 [patent_no_of_words] => 15780 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/706/06706474.pdf [firstpage_image] =>[orig_patent_app_number] => 09605558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4177124 [patent_doc_number] => 06037176 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Antisense inhibition of integrin beta 3 expression' [patent_app_type] => 1 [patent_app_number] => 9/344520 [patent_app_country] => US [patent_app_date] => 1999-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27318 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037176.pdf [firstpage_image] =>[orig_patent_app_number] => 344520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4144976 [patent_doc_number] => 06063626 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'Antisense inhibition of G-alpha-i3 expression' [patent_app_type] => 1 [patent_app_number] => 9/339775 [patent_app_country] => US [patent_app_date] => 1999-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25735 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063626.pdf [firstpage_image] =>[orig_patent_app_number] => 339775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3942753 [patent_doc_number] => 05976879 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Antisense oligonucleotides which combat aberrant splicing and methods of using the same' [patent_app_type] => 1 [patent_app_number] => 9/302390 [patent_app_country] => US [patent_app_date] => 1999-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7512 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/976/05976879.pdf [firstpage_image] =>[orig_patent_app_number] => 302390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4190474 [patent_doc_number] => 06043090 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-28 [patent_title] => 'Antisense inhibition of human Akt-2 expression' [patent_app_type] => 1 [patent_app_number] => 9/256465 [patent_app_country] => US [patent_app_date] => 1999-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25478 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/043/06043090.pdf [firstpage_image] =>[orig_patent_app_number] => 256465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4176598 [patent_doc_number] => 06037142 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Antisense inhibition of SMAD2 expression' [patent_app_type] => 1 [patent_app_number] => 9/255912 [patent_app_country] => US [patent_app_date] => 1999-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25498 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037142.pdf [firstpage_image] =>[orig_patent_app_number] => 255912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3943306 [patent_doc_number] => 05998206 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Antisense inhibiton of human G-alpha-12 expression' [patent_app_type] => 1 [patent_app_number] => 9/256496 [patent_app_country] => US [patent_app_date] => 1999-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27360 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998206.pdf [firstpage_image] =>[orig_patent_app_number] => 256496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4218253 [patent_doc_number] => 06040178 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-21 [patent_title] => 'Antisense inhibition of Smad5 expression' [patent_app_type] => 1 [patent_app_number] => 9/256492 [patent_app_country] => US [patent_app_date] => 1999-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25308 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/040/06040178.pdf [firstpage_image] =>[orig_patent_app_number] => 256492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4197028 [patent_doc_number] => 06013522 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Antisense inhibition of human Smad1 expression' [patent_app_type] => 1 [patent_app_number] => 9/255911 [patent_app_country] => US [patent_app_date] => 1999-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25309 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013522.pdf [firstpage_image] =>[orig_patent_app_number] => 255911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3978197 [patent_doc_number] => 05948680 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-07 [patent_title] => 'Antisense inhibition of Elk-1 expression' [patent_app_type] => 1 [patent_app_number] => 9/213767 [patent_app_country] => US [patent_app_date] => 1998-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25307 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/948/05948680.pdf [firstpage_image] =>[orig_patent_app_number] => 213767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3940871 [patent_doc_number] => 05989912 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Three component chimeric antisense oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 9/211795 [patent_app_country] => US [patent_app_date] => 1998-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4455 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/989/05989912.pdf [firstpage_image] =>[orig_patent_app_number] => 211795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4063264 [patent_doc_number] => 06008048 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'Antisense inhibition of EGR-1 expression' [patent_app_type] => 1 [patent_app_number] => 9/205921 [patent_app_country] => US [patent_app_date] => 1998-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25867 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/008/06008048.pdf [firstpage_image] =>[orig_patent_app_number] => 205921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3981288 [patent_doc_number] => 05958772 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'Antisense inhibition of cellular inhibitor of apoptosis-1 expression' [patent_app_type] => 1 [patent_app_number] => 9/205204 [patent_app_country] => US [patent_app_date] => 1998-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25866 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/958/05958772.pdf [firstpage_image] =>[orig_patent_app_number] => 205204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3910154 [patent_doc_number] => 06001653 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Human type 2 RNase H' [patent_app_type] => 1 [patent_app_number] => 9/203716 [patent_app_country] => US [patent_app_date] => 1998-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8094 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001653.pdf [firstpage_image] =>[orig_patent_app_number] => 203716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4093577 [patent_doc_number] => 06096543 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Antisense inhibition of human mek1 expression' [patent_app_type] => 1 [patent_app_number] => 9/197380 [patent_app_country] => US [patent_app_date] => 1998-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25569 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096543.pdf [firstpage_image] =>[orig_patent_app_number] => 197380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4083980 [patent_doc_number] => 06054560 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'Mitogen activated protein kinase, FRK' [patent_app_type] => 1 [patent_app_number] => 9/193797 [patent_app_country] => US [patent_app_date] => 1998-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 6 [patent_no_of_words] => 11160 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054560.pdf [firstpage_image] =>[orig_patent_app_number] => 193797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3934285 [patent_doc_number] => 05972708 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Plasmid stabilization' [patent_app_type] => 1 [patent_app_number] => 9/176607 [patent_app_country] => US [patent_app_date] => 1998-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10657 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972708.pdf [firstpage_image] =>[orig_patent_app_number] => 176607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4047175 [patent_doc_number] => 05968826 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Antisense inhibition of integrin .alpha.4 expression' [patent_app_type] => 1 [patent_app_number] => 9/166203 [patent_app_country] => US [patent_app_date] => 1998-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27612 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968826.pdf [firstpage_image] =>[orig_patent_app_number] => 166203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4084269 [patent_doc_number] => 06054576 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'Deprotection of RNA' [patent_app_type] => 1 [patent_app_number] => 9/164964 [patent_app_country] => US [patent_app_date] => 1998-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 5910 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054576.pdf [firstpage_image] =>[orig_patent_app_number] => 164964 [rel_patent_id] =>[rel_patent_doc_number] =>)